In Brief
The microtubule cytoskeleton is built up from a/b-tubulin heterodimers. Yu et al. develop an approach to purify functional wild-type and mutant mammalian tubulins. They identify all tubulinassociated proteins (TAPs) from HEK293T cells and show that stable tubulin-TAP interactions are required for efficient microtubule nucleation and growth.
SUMMARY
The microtubule (MT) cytoskeleton forms a dynamic filamentous network that is essential for many processes, including mitosis, cell polarity and shape, neurite outgrowth and migration, and ciliogenesis [1, 2] . MTs are built up of a/b-tubulin heterodimers, and their dynamic behavior is in part regulated by tubulin-associated proteins (TAPs). Here we describe a novel system to study mammalian tubulins and TAPs. We co-expressed equimolar amounts of triple-tagged a-tubulin and b-tubulin using a 2A ''self-cleaving'' peptide and isolated functional fluorescent tubulin dimers from transfected HEK293T cells with a rapid two-step approach. We also produced two mutant tubulins that cause brain malformations in tubulinopathy patients [3] . We then applied a paired mass-spectrometry-based method to identify tubulin-binding proteins in HEK293T cells and describe both novel and known TAPs. We find that CKAP5 and the CLASPs, which are MT plus-end-tracking proteins with TOG(L)-domains [4] , bind tubulin efficiently, as does the Golgi-associated protein GCC185, which interacts with the CLASPs [5] . The N-terminal TOGL domain of CLASP1 contributes to tubulin binding and allows CLASP1 to function as an autonomous MT-growthpromoting factor. Interestingly, mutant tubulins bind less well to a number of TAPs, including CLASPs and GCC185, and incorporate less efficiently into cellular MTs. Moreover, expression of these mutants in cells impairs several MT-growth-related processes involving TAPs. Thus, stable tubulin-TAP interactions regulate MT nucleation and growth in cells. Combined, our results provide a resource for investigating tubulin interactions and functions and widen the spectrum of tubulin-related disease mechanisms.
RESULTS AND DISCUSSION

Production of Functional Tubulin in Mammalian Cells
Microtubules (MTs) are filaments composed a/b-tubulin heterodimers that interact in a head-to-tail manner to form protofilaments, 13 of which fold up through lateral interactions to make a hollow MT tube. Assembly, or disassembly, of a MT occurs by the addition, or removal, of tubulin dimers at the ends. One end of a MT, called the minus end, is often embedded in a protective structure such as the centrosome, whereas the plus end undergoes cycles of polymerization, pausing, and depolymerization, a behavior termed dynamic instability [6] .
Functional (i.e., assembly-competent) tubulin can be purified from pig or cow brain tissue through repeated cycles of polymerization, high-speed sedimentation of MTs, and depolymerization [7] . Brain tubulin is widely used in in vitro studies, but since multiple a-and b-tubulin isotypes exist that are encoded by different genes [8] , brain-derived MTs are of a mixed isotype composition. Efforts toward isolating recombinant tubulin isotypes are hampered by the fact that tubulin biosynthesis is quite complex, involving chaperones that bind to nascent tubulin polypeptides, cytosolic chaperonins (CCTs) that facilitate folding of intermediate tubulin monomers, and tubulin-specific folding cofactors that allow formation of native heterodimers [9] . Nevertheless, purified assembly-competent recombinant human tubulin was recently obtained from baculovirus-infected insect cells, allowing studies of isotype function [10] . However, non-cleavable affinity tags were placed at the C terminus of both the a-and b-tubulin subunits, and these may influence MT behavior. Furthermore, expression in insect cells precludes analysis of mammalian-specific tubulin-associated proteins (TAPs).
We designed a so-called ''dual'' tubulin expression construct ( Figure 1A ) for the production and isolation of recombinant tubulins in mammalian cells. This construct consists of a fusion cDNA encoding b-tubulin (TUBB3) followed by a short sequence encoding a P2A ''self-cleaving'' peptide [11] and triple-tagged a-tubulin (TUBA1A). The triple tag, which was placed at the N terminus, contains a biotin-recognition sequence (biotinylated by the bacterial BirA enzyme), a Sumo* substrate peptide (recognized by Sumo* protease), and GFP ( Figure 1A, top) . Upon translation of the ''dual'' construct mRNA, the short P2A peptide cleaves in an autocatalytic fashion, resulting in the production of equimolar amounts of TUBB3 with part of the P2A peptide at its C terminus (TUBB3-P2A) and tagged TUBA1A. Analysis of the modeled structure of the tagged a/b-tubulin dimer indicated that bio-Sumo*-GFP at the N terminus of a-tubulin is not in the vicinity of the a/b-tubulin dimer interface ( Figure 1A , bottom). As controls for the ''dual'' construct, we made ''single'' bioSumo*-GFP-TUBA1A constructs, as well as another ''dual'' version in which we placed a bio-Sumo*-tag at the N terminus of b-tubulin instead of a-tubulin ( Figure S1A ).
We expressed ''single'' or ''dual'' constructs in HEK293T cells together with a plasmid encoding the BirA biotin ligase. Transfected cells were lysed, and biotinylated tubulin was purified using streptavidin-coated magnetic beads. After washing, proteins were cleaved off of the beads with Sumo* protease. SDS-PAGE followed by Coomassie staining (Figures 1B and S1B) or western blotting (Figures S1C and S1D) was used to examine protein expression, purification, and cleavage. We detected biotinylated and Sumo*-GFP-tagged a-tubulin ($110 kDa) on beads after purification. Cleavage with Sumo* protease resulted in the disappearance of the $110 kDa protein and the appearance of GFPa-tubulin ($85 kDa). In addition, we co-purified proteins of $55kDa ( Figures 1B and S1B ), which were identified as tubulins by western blot (Figures S1C and S1D), and proteins of $70 kDa (asterisks in Figures 1B and S1B ), which are discussed below. When wild-type GFP-TUBA1A was expressed using the ''dual'' construct, the amount of b-tubulin that co-purified with GFP-TU-BA1A was higher compared to the ''single'' construct due to increased TUBB3-P2A (compare Figure 1B with Figure S1B ). This indicates that simultaneous synthesis of a-and b-tubulin polypeptides promotes dimer formation. Furthermore, tubulin dimer pull-down was less efficient when the biotin tag was placed at the N terminus of b-tubulin (data not shown). Taken together, these data suggest that our production and isolation method yields soluble recombinant tubulin and that dimer pulldown is most effective when a-tubulin is tagged.
The conformation of HEK293T-purified wild-type tubulin was examined by gel filtration. Compared to brain tubulin, which Figure 2E . See also Figure S1 and Movie S1.
eluted as a single dimeric species, HEK-purified GFP-tagged tubulin eluted slightly earlier ( Figure 1C) , consistent with the presence of a GFP moiety on tubulin. SDS-PAGE and Coomassie staining of eluted fractions suggested that this peak consisted of GFP-a-tubulin/b-tubulin heterodimers and complexes of GFP-tubulin with $70 kDa proteins. A mass-spectrometrybased analysis of purified fractions revealed that the latter are HSPA heat shock proteins (data not shown). We next mixed HEK-purified tubulin with brain tubulin and GMPCPP (a slowly hydrolyzable GTP analog), allowed MTs to form, and performed a MT sedimentation assay. Approximately 70% of the total HEKpurified GFP-a-tubulin incorporated into MTs ( Figure 1E ). Furthermore, an in vitro total internal reflection fluorescence (TIRF)-microscopy-based assay [12] , in which a mixture of purified GFP-TUBA1A, brain tubulin, and other components was added to a functionalized chamber with GMPCPP-stabilized MT seeds, revealed incorporation of fluorescent tubulin into dynamic MTs ( Figure 1F ; Movie S1). Thus, GFP-tagged tubulin produced using the ''dual'' strategy is assembly competent.
The importance of the different tubulin isotypes for neuronal function is underscored by the finding of mutations in the tubulin genes that give rise to a spectrum of human neuro-developmental disorders. These are collectively called tubulinopathies, and they arise because of problems in neuronal migration or differentiation [3] . To study mutant tubulins, we introduced two mutations (P263T and R402H) into TUBA1A ( Figure 1A ) that lead to problems in vivo [13] but that do not impair the capacity of mutant tubulins to form heterodimers in vitro [14] . Expression of the P263T and R402H mutants in differentiating N1E-115 cells indeed affected neurite outgrowth (Figures S1E and S1F). The tagged mutant tubulins were purified in soluble form from HEK293T cells and were cleaved with Sumo* protease, like wild-type tubulin ( Figure S1D ).
Collectively, our data demonstrate that the isolation of recombinant tubulin from transiently transfected HEK293T cells using a ''dual'' expression method followed by biotin-streptavidin pulldown and Sumo* protease cleavage yields assembly-competent fluorescent a/b-tubulin dimers. This approach can be further developed to study tubulin isotypes, also from different species, and the effect of tubulin mutations on MT behavior in vitro. It should be noted that tubulins undergo a number of posttranslational modifications (PTMs), some of which occur on the C-terminal residues of a-and b-tubulin [15] . In our ''dual'' expression approach, the C terminus of b-tubulin contains part of the P2A ''self-cleaving'' peptide; this is highly likely to impair C-terminal PTMs on this subunit.
Identification of Tubulin Associated Proteins
The dynamic behavior of MTs is regulated both by TAPs and MTassociated proteins (MAPs). The latter are often divided into subgroups according to their mode of association with MTs. For example, ''classic'' MAPs, like MAP2, MAP1B, and MAP4, bind along the MT lattice, motor proteins move along MTs, and MT plus-end-tracking proteins (+TIPs) associate specifically with the ends of growing MTs. Although many MAPs and +TIPs have been identified over the years, we are aware of only two unbiased approaches to detect TAPs. In the first, a tubulin affinity matrix was used; this strategy yielded 122 potential plant TAPs, of which one was a tubulin chaperone and six others, including plant CLASP, were similar to known MAPs [16] . In the second approach, a tubulin-antibody matrix was used to isolate TAPs from extracts of HeLa cells [17] ; however, this indirect approach did not yield a high number of proteins.
To identify mammalian TAPs, we expressed tagged tubulins in HEK293T cells, purified them on streptavidin beads, and used a paired mass-spectrometry-based approach to screen for interaction partners. In this strategy, one sample contained proteins that were boiled off streptavidin beads and identified by mass spectrometry, whereas in a second sample the streptavidinlinked material was treated with Sumo* protease and the released proteins were analyzed by mass spectrometry. The rationale behind this approach is that proteins that show a strong preference for tubulin-bound streptavidin beads and that are efficiently released by Sumo* protease are likely to be TAPs. By contrast, contaminants such as endogenously biotinylated mitochondrial proteins should be present in the bead fractions of the different samples, including the negative control (BioSumo*-GFP), but not in Sumo*-protease-released fractions.
We obtained 3,091 entries for proteins co-purifying with ''dual'' tubulin (Table S1 ). Although most TAPs were novel, some were previously shown to bind tubulin, validating our approach. In addition, we did not detect MAP1B, MAP2, or MAP4, the +TIPs EB1 or EB3, or conventional kinesin, indicating that the pull-downs were specific for TAPs. We verified mass spectrometry results using western blot analysis and showed that four prominent TAPs (i.e., CKAP5, CLASP1, CLASP2, and GCC185 [or GCC2]) did bind tubulin, whereas EB1, the ''core'' +TIP that recruits many other +TIPs to MT ends [18] , did not ( Figure S2A ). We also showed that the ''dual'' construct depicted in Figure 1A brings down TAPs more efficiently than other constructs ( Figures S1A and S2B) . Together, these results indicate that the proteins listed in Table S1 represent a considerable fraction of the HEK293T cell ''tubulome.'' By applying stringent criteria (see the Supplemental Experimental Procedures for explanation) we selected the 45 most prominent TAPs and classified these according to known function or localization (Table 1) . Of these TAPs, the majority (80%) are novel. To estimate their abundance, we examined the HEK293T transcriptome using next-generation sequencing. This revealed that most TAPs are expressed at considerably lower levels than the chaperonins, which have FPKM (fragments per kilobase of transcript per million mapped reads) values of well over a 100 (data not shown). Thus, the presence of the TAPs in Table 1 appears to reflect an affinity for a-tubulin, rather than cellular abundance.
We observed several general features in Table 1 . First, many of the TAPs interact with other TAPs, often of the same category. For example, CEP97 and CCP110 are interacting centrosomal proteins with a role in preventing excessive centriole growth [19] . Also, CLIP-115 binds the CLASPs [20] , and SLAINs have been shown to interact with CLASPs, CKAP5, and CLIP-115 [21] . These results suggest the existence of higher-order tubulin-TAP complexes with important functions in MT and/or centrosome and/or cilia behavior. For example, the tubulinbinding +TIPs might form a core network that promotes MT growth at plus ends and other intracellular sites. A second observation, which was verified by western blot (Figure S2C) , was that for a number of TAPs, including the CLASPs, GCC185, and various centrosomal components, fewer unique peptides were found in the mass-spectrometry-based pull-downs of the mutant tubulins (Tables 1 and S1 ). Finally, several TAPs (underlined in Table 1 ) have been found mutated in patients with brain malformations or ciliopathies. This underscores the importance of TAPs for brain development and ciliogenesis. It would be interesting to investigate whether other TAPs in Table 1 are mutated in patients with neurological symptoms.
Tubulin Binding Stimulates the MT-Growth-Promoting Capacity of CLASP1
Among the highest-ranking TAPs in the ''tubulome'' of HEK cells are CKAP5 (also called XMAP215 or Ch-TOG) and the CLASPs, which are +TIPs with similar domains, termed TOG in the case of CKAP5 and TOGL in the case of CLASPs [4] . CKAP5 acts as a MT polymerase by binding tubulin subunits with its TOG domains and mediating the incorporation of tubulin at MT ends [22] . Tubulin binding has also been described for yeast CLASP, which was suggested to promote MT rescue by recruiting tubulin dimers to the MT [23] , but not for mammalian CLASP1 and CLASP2. These proteins are encoded by different genes and exist as multiple isoforms [20] , the longest of which (a) contains three TOGL domains, whereas shorter isoforms (b, g) only have two (Figure 2A ). Recent studies suggest that the TOGL domains in CLASP2g do not have an optimal tubulin-binding interface as they assume a curved conformation; these domains were instead proposed to have a preference for MTs [27] . To examine tubulin binding by CLASP isoforms, we co-expressed biotinylated and GFP-tagged ''dual'' tubulin together with YFP, YFP-CLASP1a, or YFP-CLASP2g, pulled down biotinylated tubulin, and found that YFP-CLASP1a co-precipitated much more efficiently than YFP-CLASP2g (Figure 2A, bottom) . These results suggest that the TOGL1 domain contributes significantly to tubulin binding of CLASP1a. The majority of +TIPs, including the CLASPs, have been shown to harbor a small domain (called the SxIP motif) with which they interact with EB proteins and that allows them to accumulate at growing MT ends [18] . In fact, the EB proteins are seen as the ''core'' +TIPs because they attract most other +TIPs yet bind MT ends in an autonomous fashion [12] . We purified GFP-tagged CLASP1a and CLASP2g from HEK293T cells (Figures 2B, S3A , and S3B), as well as GFPtagged and non-tagged (''dark'') EB3 ( Figures S3C and S3D and data not shown), and examined binding of CLASP isoforms to in vitro-grown MTs, as well as their effect on MT dynamics, using the aforementioned TIRF-microscopy-based assay. CLASP2g displayed typical +TIP behavior as it accumulated on MT ends in the presence of EB3 (Figures 2C and 2D ) and did not bind MTs in the absence of EB3 (data not shown). Strikingly, CLASP1a bound to MT ends and the MT lattice in the absence of EB3; addition of the ''core'' +TIP shifted CLASP1a binding toward the MT end ( Figures 2C and 2D) . Thus, the presence of the tubulin-binding TOGL1 domain allows CLASP1a to bind MTs and MT ends autonomously.
We then measured dynamic parameters of in vitro-polymerizing MTs grown in the presence or absence of EB3 and the Figure S2 and Table S1 . CLASPs. The addition of EB3 and GFP-CLASP1a or of EB3 and GFP-CLASP2g caused a general dampening of MT dynamic behavior compared to MTs grown in the presence of EB3 only ( Figure 2E ). Interestingly, when added on its own GFP-CLASP1a also reduced MT growth rates, and it virtually eliminated MT catastrophes while increasing rescue frequency ( Figure 2E ). Thus, consistent with cellular data [28] , CLASPs stabilize MT growth by acting both as anti-catastrophe and rescue factors. However, while CLASP2g only exerts its function in the presence of EB proteins, the tubulin-binding TOGL1-domain allows CLASP1a to promote continuous MT growth in an autonomous fashion. These data suggest that CLASP isoforms use different mechanisms to stimulate MT growth.
Stable Tubulin-TAP Interactions Are Required for Efficient MT Nucleation and Growth
Mutations that give rise to tubulinopathies are thought to perturb neuronal migration and differentiation because of defective tubulin dimer formation, hampered MT dynamics, and/or reduced binding of MAPs to MTs [29] [30] [31] . However, our finding that mutant tubulins interact less well with a selected number of TAPs suggested that MT-based processes that depend on these TAPs might also be perturbed in tubulinopathy patients. We therefore examined the intracellular behavior of the P263T and R402H mutants in more detail. We first confirmed that wild-type and mutant GFP-tubulins are expressed at similar levels in RPE1 cells ( Figure S4A ). We then examined live RPE1 cells, and we observed fluorescent MT networks less frequently in cells expressing mutant tubulins (Figure S4B) . These mutants appeared to be assembly competent, as we detected MTs in virtually all cells after the addition of paclitaxel, a MT-stabilizing agent ( Figure S4B) . However, the fluorescence intensity of mutant MTs was less than that of MTs containing GFP-tagged wild-type tubulin ( Figure S4C ), suggesting that mutant tubulins incorporate less efficiently into MTs. To examine GFP-tubulin properties in more detail, we turned to fixed cells. 1-3) and the serine-rich EBbinding region (gray rectangle) are indicated. HEK cells expressing bio-Sumo*-GFP-tubulin and the indicated YFP-tagged proteins were lysed, and the interaction of the YFP-tagged proteins with tubulin was examined by streptavidin-based pull-down using anti-GFP antibodies. Molecular weights of marker proteins are indicated to the left. (B) Purification of GFP-CLASP1a and GFPCLASP2g. HEK cells expressing bio-Sumo*-GFPCLASP1a or bio-Sumo*-GFP-CLASP2g were lysed, and fusion proteins were purified using streptavidin beads. GFP-tagged proteins were cleaved off the beads using Sumo* protease and checked for purity on Coomassie-stained gels. M, marker lane (molecular weights are indicated to the left). (E) Parameters of dynamic MT behavior. Experiments were performed in the presence of 15 mM tubulin, 75 nM EB3, and 38 nM CLASPs. MT growth and shrinkage rates are shown ±SD. F c , catastrophe frequency; F r , rescue frequency; N, number of MTs measured. Note that MT behavior in the absence of +TIPs is similar to previous data (e.g., [24, 25] ; see also Figure 1G ). Furthermore, as reported (e.g., [24, 26] ), we found that addition of EB3 accelerated MT growth rate and enhanced the frequencies of catastrophes and rescues of in vitro polymerizing MTs. See also Figure S3 .
Control experiments indicated that a quick pre-extraction of cells prior to fixation removes soluble GFP signal without affecting the MT network ( Figure S4D) . To measure the level of MT-bound GFP-tubulin, we therefore analyzed fluorescence in cells that were first pre-extracted and then fixed with paraformaldehyde. To measure the total amount of GFP-tubulin (i.e., soluble and MT bound), we examined cells that were fixed in paraformaldehyde without pre-extraction. We found that 34% of GFP-tubulin was in MTs in cells cultured under normal conditions ( Figure 3A,  left) . By contrast, in cells treated with paclitaxel, 75% of GFPtubulin was MT bound ( Figure 3A, right) , suggesting that 75% of wild-type GFP-tubulin is assembly competent. This result is consistent with our MT pelleting result in Figure 1E . We next compared the capacity of wild-type and mutant tubulins to incorporate into MTs by measuring fluorescence intensities of MT segments in pre-extracted, fixed cells ( Figure 3B ; note that MTs were outlined with the help of anti-tubulin antibodies, see Figure 3C ). In cells cultured under normal conditions, the mutant tubulins incorporated less efficiently into MTs as compared to the wild-type ( Figures 3B, 3C , and S4E), in line with results in live RPE1 cells ( Figure S4C ). Strikingly, in paclitaxel-treated cells, the mutants incorporated better than wild-type tubulin ( Figures 3B, 3C, and S4E ). These data strongly suggest that mutant tubulins are fully assembly competent, raising the question of why they do not incorporate efficiently into MTs under normal conditions. We propose that the reduced binding of mutant tubulins to CLASPs and CKAP5 ( Figure S2C ) contributes to their reduced incorporation into MT ends. We furthermore note that the improved incorporation of mutant tubulins after paclitaxel treatment opens perspectives for treatment of tubulinopathy patients, not with paclitaxel, as this compound does not pass the blood-brain barrier, but perhaps with epothilone B, a MT-stabilizing agent that does [32] .
Tubulin dimers have an intrinsic capacity to self-organize into MTs in a process known as MT nucleation. However, the kinetic barrier is high, meaning that the efficiency with which MTs spontaneously nucleate is very low. In cells MT nucleation therefore occurs in MT -organizing centers (MTOCs), of which the centrosome is the major one. However, non-centrosomal MT nucleation, for example at the Golgi apparatus, is also common in cells. As Golgi-mediated MT nucleation depends on GCC185 and the CLASPs [5] and mutant tubulins bind these proteins less efficiently, we investigated whether expression of the mutants affects this process. We treated RPE1 cells with nocodazole, a MT-depolymerizing agent, and first examined incorporation of GFP-tubulin at the centrosome and Golgi after nocodazole washout. Nocodazole treatment almost completely abolished the MT network and caused dispersal of the Golgi (Figure 3D) . Seven minutes after washout, GFP-labeled centrosomal and non-centrosomal MTs were detected in cells transfected with wild-type tubulin, but in cells expressing TUBA1A-P263T or TUBA1A-R402H we did not observe any incorporation of mutant tubulin into regrowing MTs ( Figure 3E ; see also quantification in Figure 3G ). By contrast, 30 min after washout, we did observe MTs with fluorescent TUBA1A-P263T or TUBA1A-R402H ( Figure 3F ).
To examine re-growth of the complete MT network, we stained cells with anti-a-tubulin. This revealed that MTs do form early on after washout ( Figure 3E ). Interestingly, although the mutant tubulins themselves did not incorporate into Golgiderived MTs at early time points, their presence did hamper formation of these MTs ( Figure 3G ). MT nucleation at the Golgi has been suggested to proceed in a step-wise fashion, with GCC185 providing a Golgi-based docking platform for the CLASPs and the CLASPs in turn stimulating MT growth by binding nascent MTs [5] . Our in vitro results support the idea that CLASPs promote MT growth. However, GCC185 also binds tubulin; in fact, like the CLASPs, GCC185 is one of the prominent TAPs identified in this study (Tables 1 and S1 ). As mutant tubulins bind less efficiently to CLASPs and GCC185 and expression of these mutants hampers Golgi-mediated MT nucleation in cells, we propose that tubulin-CLASP, tubulin-GCC185, and CLASP-GCC185 interactions are all important for setting up a platform at the Golgi for efficient MT nucleation.
Finally, since mutant tubulins also interacted less efficiently with TAPs that are important for cilia formation, we tested whether ciliogenesis is affected in RPE1 cells expressing the mutants. We found that the percentage of RPE1 cells with cilia was reduced upon expression of both mutants; in addition, TUBA1A-R402H expression affected ciliary length ( Figures S4F  and S4G) . We conclude that mutant tubulins hamper both ciliogenesis and non-centrosomal MT nucleation. The P263T and R402H mutants may affect these processes by competing with normal tubulin for TAPs. It is noteworthy that Golgi-mediated MT nucleation contributes to directed cell motility [33] and that cilia are important for directed neuronal migration [34] . Thus, reduced tubulin-TAP interactions may cause neuronal migration problems in tubulinopathy patients due to defective cilia and Golgi-based MT nucleation. Together, our data widen the spectrum of MT-mediated processes that are deregulated in the tubulinopathies.
Conclusions
We have developed an approach to express and purify functional mammalian tubulin dimers from transiently transfected cells. We used this method to identify TAPs in cultured HEK293T cells. This ''tubulome,'' which contains many novel factors, includes CKAP5 and the CLASPs, which are MT plusend-tracking proteins with multiple TOG(L)-domains, and GCC185, a Golgi-associated protein that binds CLASPs. We show that the N-terminal TOGL1 domain is required for efficient tubulin binding by CLASP1 and allows CLASP1 to promote MT growth in an autonomous manner. Furthermore, two mutant tubulins, known to cause brain malformation and neuronal differentiation defects in tubulinopathy patients, bind less efficiently to certain TAPs, incorporate less well into MTs, and impair intracellular processes involving TAPs. Thus, stable tubulin-TAP interactions, which are perturbed by tubulin mutations, are required for efficient MT nucleation and growth. Our results provide a resource for investigating tubulin interactions and functions and widen the spectrum of tubulin-related disease mechanisms.
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